AstraZeneca PLC (AZN)
AstraZeneca Market Cap : 316.57B for Feb. 20, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| GSK Plc | 119.44B |
| Mereo BioPharma Group Plc | 67.40M |
| Regeneron Pharmaceuticals, Inc. | 82.43B |
| Biodexa Pharmaceuticals Plc | 0.973M |
| Bicycle Therapeutics Plc | 372.51M |
Market Cap Related Metrics
| PE Ratio | 62.28 |
| PS Ratio | 10.84 |
| PEG Ratio | 1.360 |
| Price to Book Value | 6.899 |
| Price to Free Cash Flow | 71.02 |
| Price | 204.20 |
| Earnings Yield | 1.61% |
| PEGY Ratio | 1.316 |
| Operating PE Ratio | 46.81 |